buyWeak
Bradford T Whitmore bought $600k of CLSD
owner at Clearside Biomedical, Inc.. 444,444 shares at an average of $1.35, traded Feb 7, 2024, filed Feb 9, 2024.
Conviction score
24Value
$600k
444,444 shares
Holdings after
4,495,034
+11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +19Trade size$600k at market
- +3Relative to holdingsHoldings up 11%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- -5Track recordMedian 6-month excess return -26% over 8 past buys
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000933430-24-000001, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 7, 2024 | POpen-market purchase Common Stock | +444,444 | $1.35 | $600k | 4,495,034 | Feb 9, 2024 |
| Feb 7, 2024 | POpen-market purchase Warrantderivative | +444,444 | $0.00 | $0 | 444,444 | Feb 9, 2024 |
Related signals
Other insiders at Clearside Biomedical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | CLSDbuy Clearside Biomedical, Inc. | Clay Thorp director | $14k 15,000 shares | +9% | |
| 31Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong Chief Medical Officer | $37k 36,500 shares | +57% | |
| 25Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong Chief Medical Officer | $25k 23,500 shares | +59% | |
| 25Weak | CLSDbuy Clearside Biomedical, Inc. | Benjamin R Yerxa director | $10k 7,813 shares | +77% | |
| 34Weak | CLSDbuy Clearside Biomedical, Inc. | Anthony S Gibney director | $130k 100,000 shares | - | |
| 30Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong CHIEF MEDICAL OFFICER | $48k 30,000 shares | - | |
| 30Weak | Clearside Biomedical, Inc. | Charles A. Deignan Chief Financial Officer | $17k 12,900 shares | -3% | |
| 33Weak | Clearside Biomedical, Inc. | George M Lasezkay CEO | $23k 18,000 shares | -4% | |
| 12Weak | CLSDbuy Clearside Biomedical, Inc. | Bradford T Whitmore owner | $100k 135,778 shares | +3% | |
| 25Weak | CLSDbuy Clearside Biomedical, Inc. | Clay Thorp director | $14k 14,000 shares | +85% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.